Keren-Or Amar
Director/Board Member at NewStem Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ilya Pittel | M | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel.
Bar-Ilan University
| 17 years |
Simon Benita | M | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
Itzik Goldwaser | M | - |
NewStem Ltd.
NewStem Ltd. Packaged SoftwareTechnology Services NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah.
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | 5 years |
Nissim Benvenisty | M | - |
NewStem Ltd.
NewStem Ltd. Packaged SoftwareTechnology Services NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah. | 8 years |
Yaron Daniely | M | 48 |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Jan Loeb | M | 64 |
NewStem Ltd.
NewStem Ltd. Packaged SoftwareTechnology Services NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah. | - |
Yoram Titez | M | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Alon Moran | M | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
Shimrit Frankel | F | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | 12 years |
Anna Pellivert | F | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | 5 years |
Ayelet Dilion Mashiah | F | - |
NewStem Ltd.
NewStem Ltd. Packaged SoftwareTechnology Services NewStem Ltd. is an Israeli company that aims to revolutionize the life sciences industry and the development of therapeutics and diagnostics. The company is based in Givat Ram, Israel. The company has a deep understanding of human stem cells and use their proprietary technology of haploid human embryonic stem cells to achieve their goals. The company was founded in 2016 by Nissim Benvenisty. The CEO is Ayelet Dilion Mashiah. | - |
Reem Sari | F | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Yishai Fraenkel | M | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Hermona Soreq | M | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Roy Navon | M | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Ari Kellen | M | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | 6 years |
Itamar Borowitz | M | 80 |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | 8 years |
Ariela Markel | F | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Sharon Cohen | F | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | 14 years |
Gideon Federmann | M | 46 |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Gadi Tirosh | M | 57 |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Osnat Ronen | F | 61 |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Yehudit Bronicki | M | 82 |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | - |
Robert Trachtenberg | M | - |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | 18 years |
I. Edelson | M | 64 |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
Joelle Aflalo | F | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joseph Papa | M | 68 |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
Ronny Lempel | M | - |
Technion-Israel Institute of Technology
| 10 years |
Ronen Nakash | M | - |
Technion-Israel Institute of Technology
| 16 years |
Lihi Manashcu | F | 37 |
Bar-Ilan University
| 7 years |
Ariel Sverdlik | M | 55 |
Technion-Israel Institute of Technology
| 9 years |
Gat Yulevitch | F | - |
Bar-Ilan University
| 5 years |
Ziv Hashai | M | 44 |
Bar-Ilan University
| 8 years |
Dudi Klein | M | - |
Bar-Ilan University
| 8 years |
Gita Reinitz | M | - |
Bar-Ilan University
| 5 years |
Dana Shahar | F | - |
Bar-Ilan University
| 2 years |
Avraham Assulin | M | 43 |
Bar-Ilan University
Technion-Israel Institute of Technology
| 9 years |
Meir Simcha | M | 47 |
Technion-Israel Institute of Technology
| 6 years |
Tahel Noy | M | - |
Technion-Israel Institute of Technology
| 6 years |
Gilad Shainer | M | - |
Technion-Israel Institute of Technology
| 6 years |
Roei Sella | M | 43 |
Bar-Ilan University
| 7 years |
Asa Levinger | M | 47 |
Technion-Israel Institute of Technology
| 8 years |
Meirav Rachel Wolkinson | F | 48 |
Bar-Ilan University
| 3 years |
Yaniv Shlomo Haver | M | 47 |
Bar-Ilan University
| 6 years |
Ronen Yehuda | M | - |
Bar-Ilan University
| 7 years |
Dudi Peru | M | - |
Bar-Ilan University
| 4 years |
Dudi Peles | M | - |
Bar-Ilan University
| 5 years |
Bobi Gilburd | M | - |
Technion-Israel Institute of Technology
| 3 years |
Merav Shoval Hinkis | F | - |
Bar-Ilan University
| 9 years |
Lihu Avitov | M | 53 |
Technion-Israel Institute of Technology
| 7 years |
Zechariah Reich | M | - |
Bar-Ilan University
| 3 years |
Matan Ofir | M | - |
Bar-Ilan University
| 3 years |
Dmitry Volkinshtein | M | - |
Technion-Israel Institute of Technology
| 4 years |
Niv Ein-Gal | M | - |
Technion-Israel Institute of Technology
| 4 years |
Gil Eyal | M | - |
Bar-Ilan University
| 4 years |
Guy Waiskopf | M | 38 |
Bar-Ilan University
| 4 years |
AVIAD BEN-LAISH | M | - |
Bar-Ilan University
| 3 years |
Tamir Rabina | M | 49 |
Bar-Ilan University
| 3 years |
Leah Spitz Goldenhersh | F | - |
Bar-Ilan University
| 5 years |
Elena Winefeld | F | - |
Technion-Israel Institute of Technology
| 4 years |
Noah Lasson | M | - |
Bar-Ilan University
| 2 years |
Amir Oliker | M | - |
Bar-Ilan University
| 1 years |
Ofer Barash | M | - |
Bar-Ilan University
| 1 years |
Eyal Cohen | M | 53 |
Technion-Israel Institute of Technology
| 4 years |
Uzi Gabsi | M | - |
Bar-Ilan University
| 4 years |
Yefi Gureni | M | 51 |
Technion-Israel Institute of Technology
| 4 years |
Ariel Ben Dayan | M | 49 |
Bar-Ilan University
| 3 years |
Orly Huberman | F | 56 |
Bar-Ilan University
| 2 years |
Jenik Aviram | M | - |
Technion-Israel Institute of Technology
| 4 years |
Tamir Sagi | M | 52 |
Bar-Ilan University
| 3 years |
Oren Bar-On | M | 52 |
Technion-Israel Institute of Technology
| 4 years |
Shosh Merchav | M | - |
Technion-Israel Institute of Technology
| 16 years |
Yaron Shalem | M | 52 |
Bar-Ilan University
| 2 years |
Ilya Vorobeichik | M | - |
Technion-Israel Institute of Technology
| 3 years |
Eitan Konstantino | M | 57 |
Technion-Israel Institute of Technology
| 3 years |
Jacob Kriesler | M | 61 |
Bar-Ilan University
| 3 years |
Ami Barlev | M | 45 |
Bar-Ilan University
| 3 years |
Fuad Fares | M | 68 |
Technion-Israel Institute of Technology
| 2 years |
Wayne L. Firestone | M | - |
Technion-Israel Institute of Technology
| 3 years |
Alexander Lerner | M | - |
Technion-Israel Institute of Technology
| 3 years |
Miki Elad | M | - |
Technion-Israel Institute of Technology
| 3 years |
Michal Ben-Attar | M | - |
Bar-Ilan University
| 3 years |
Gamliel Shitrit | M | - |
Technion-Israel Institute of Technology
| 4 years |
Yosef Gvura | M | 53 |
Bar-Ilan University
| 3 years |
Yoav Kimchy | M | 63 |
Technion-Israel Institute of Technology
| 6 years |
Moshe Golani | M | 56 |
Technion-Israel Institute of Technology
| 4 years |
Orly Kyram | F | 50 |
Bar-Ilan University
| 3 years |
Roi Bar-Kat | M | - |
Technion-Israel Institute of Technology
| 2 years |
Eyal Orion | M | - |
Technion-Israel Institute of Technology
| 7 years |
Itay Katz | M | - |
Technion-Israel Institute of Technology
| 4 years |
Tamir Ben-Shoshan | M | - |
Technion-Israel Institute of Technology
| 1 years |
Shir Goldberg | M | - |
Technion-Israel Institute of Technology
| 4 years |
Inbal Shmula Hillel | F | 47 |
Bar-Ilan University
| 1 years |
Guy Tartakovsky | M | - |
Technion-Israel Institute of Technology
| 4 years |
Idan Katz | M | - |
Technion-Israel Institute of Technology
| 3 years |
Yosef Margalit | F | 41 |
Bar-Ilan University
| 4 years |
Dany Eshchar | M | 65 |
Technion-Israel Institute of Technology
| 2 years |
Gilad Engel | M | - |
Bar-Ilan University
| 3 years |
Naomi Meir Shapiro | F | 45 |
Bar-Ilan University
| 2 years |
Shady Shoukair | M | - |
Bar-Ilan University
| 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Keren-Or Amar
- Personal Network